A Multicenter, Open-Label, Long-Term Study to Evaluate the Efficacy and Safety of LY2439821 in Japanese Patients With Moderate-to-Severe Psoriasis
收藏DataCite Commons2024-12-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004503/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will assess the safety and efficacy of ixekizumab in participants with moderate to severe psoriasis in Japan.
提供机构：
Vivli
创建时间：
2019-09-09
